Low- and no-calorie sweeteners lack shared target organs or modes of action required for cumulative risk assessment
Food and Chemical Toxicology · 2026
DOI: 10.1016/j.fct.2026.116424 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Food and Chemical Toxicology, 2026. Verfasst von Heather R Schaefer und 2 weiteren Autor:innen. Beteiligte Einrichtung: ToxStrategies LLC, 31 College Place, Suite 118, Asheville, NC, 28801, United States. Electronic address: hschaefer@toxstrategies.com. Hauptthemen laut MEDLINE: Sweetening Agents. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVE: The safety of individual low- and no-calorie sweeteners (LNCS) has been well established over decades, yet interest has grown in potential combined effects from concurrent exposure. This study evaluated (a) whether existing cumulative risk assessment (CRA) frameworks are appropriate for LNCS and (b) their applicability to aspartame, saccharin, sucralose, acesulfame-K, steviol glycosides, and cyclamate. METHODS: Regulatory CRA guidance and safety evaluations for each LNCS were reviewed. Toxicological data from repeat-dose and reproductive/developmental studies were synthesized by organ system and effect thresholds. A structured review of human microbiome studies was also conducted. Evidence was assessed for shared structure, target organ toxicity, and mode of action relevant to CRA frameworks. RESULTS: Existing frameworks rely on grouping chemicals with shared structure or mode of action; however, LNCS lack common structural features, toxicological profiles, and target organ effects. Kidney findings observed at high doses were inconsistent, species-specific, and considered toxicologically insignificant. Microbiome effects were variable, sweetener-specific, and not indicative of cumulative impact. CONCLUSIONS: LNCS do not exhibit properties necessary for cumulative assessment under established CRA methods. Evidence supports no cumulative effects at typical intake levels, reinforcing the adequacy of individual acceptable daily intakes (ADIs) for safety evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ToxStrategies LLC, 31 College Place, Suite 118, Asheville, NC, 28801, United States. Electronic address: hschaefer@toxstrategies.com.
- ToxStrategies LLC, 31 College Place, Suite 118, Asheville, NC, 28801, United States.
Zitieren
APA
Schaefer, H. R., Frankenfeld, C. L., & Wikoff, D. (2026). Low- and no-calorie sweeteners lack shared target organs or modes of action required for cumulative risk assessment. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2026.116424
Vancouver
Schaefer HR, Frankenfeld CL, Wikoff D. Low- and no-calorie sweeteners lack shared target organs or modes of action required for cumulative risk assessment. Food and Chemical Toxicology. 2026. doi:10.1016/j.fct.2026.116424
BibTeX
@article{Schaefer2026,
author = {Schaefer, Heather R and Frankenfeld, Cara L and Wikoff, Daniele},
title = {Low- and no-calorie sweeteners lack shared target organs or modes of action required for cumulative risk assessment},
journal = {Food and Chemical Toxicology},
year = {2026},
doi = {10.1016/j.fct.2026.116424}
}
EUVIMED